AstraZeneca Plc (AZN.L) is considering options for its Indian unit, including buying the remaining 10 percent of AstraZeneca Pharma India Ltd (ASTR.NS) in order to secure full ownership in a key emerging market. International companies have until mid-2013 under Indian regulatory rules to either reduce their stake below 75 percent or delist their Indian operations, after buying out minority shareholders. "We continue to consider two options, reducing our shareholding to the new statutory maximum of 75 percent and delisting," said a company spokeswoman in London.
